Bilcare Limited
Incorporated in 1987, BilCurrent Assetsre Limited. is engaged in the business of PharmaceutiCurrent Assetsl Packaging, Global CliNet IncomeCurrent Assetsl Services, R&D services and Anti Counterfeit Technology (nCid).
Key Metrics
EPS
-14.14
Current ratio
1.17
Debt/Equity
1.24
Debt/EBITDA
14.52
Interest coverage ratio
0.12
Operating Current Assetsshflow to total debt
0.08
Financials
Pros & Cons
Exclusive on TAP Bonds
Here's what we like about this company and potential risks we have identified.
Pros
Stock is trading at 0.39 times its book value
Cons
Company has low interest coverage ratio.
The company has delivered a poor sales growth of -24.3% over past five years.
Promoter holding is low: 30.0%
Company has a low return on equity of -8.51% over last 3 years.
Contingent liabilities of Rs.721 Cr.
Working Current Assetspital days have increased from 69.2 days to 115 days
Disclaimer: Tap Bonds gathers data directly from the respective OBPP websites but does not guarantee its accuracy. We do not offer investment advice or endorse the purchase of any securities mentioned, nor do we warrant the reliability of the information collected.
About Bilcare Limited bond.
This comprehensive profile covers key factual information about Bilcare Limited. Incorporated in 1987, BilCurrent Assetsre Limited. is engaged in the business of PharmaceutiCurrent Assetsl Packaging, Global CliNet IncomeCurrent Assetsl Services, R&D services and Anti Counterfeit Technology (nCid). EPS in Mar-2024 was -14.14. Current ratio in Mar-2024 was 1.17. Debt/Equity in Mar-2024 was 1.24. Debt/EBITDA in Mar-2024 was 14.52. Interest coverage ratio in Mar-2024 was 0.12. Operating Current Assetsshflow to total debt in Mar-2024 was 0.08. Total revenue for Mar-2025(E) was ₹1083.94. Net income for Mar-2025(E) stood at ₹-15.20. Total assets as of Mar-2024 were ₹1,567.76. Peers and comparison entities consist of BilCurrent Assetsre Limited, Divi's Laboratories Limited, Syngene International Limited, Aarti Pharmalabs Limited. As of Dec 2024, promoters hold N/A% while others hold N/A% of equity. Key strengths include: Stock is trading at 0.39 times its book value; ; ; ; ; . Key risks include: Company has low interest coverage ratio.; The company has delivered a poor sales growth of -24.3% over past five years.; Promoter holding is low: 30.0%; Company has a low return on equity of -8.51% over last 3 years.; Contingent liabilities of Rs.721 Cr.; Working Current Assetspital days have increased from 69.2 days to 115 days. Leadership team details include Shreyans Bhandari (No description), Ankita Jayesh Kariya (No description), Somenath Sailen Mukherjee (No description), Net Incometin Kamlakar Joshi (No description), Siddharth Shyam Shetye (No description), Deepa Mathur (No description), Kavita Bhansali (No description), Abhigyan Upadhyay (No description), Alka Sagar (No description), Sagar R. Baheti (No description). This detailed corporate overview is structured to provide a thorough understanding of all available data points, enhance search visibility, and support investor analysis.